Kamada

Kamada is a company listed under the stock ticker KMDA (IL).

View the org chart displaying its 21 main executives

Most searched biographies at Kamada

• Amir London, Chief Executive Officer
• David Tsur, Vice Chairman of the Board
• Ari Shamiss, Director

Create your alert
to follow the executive moves at Kamada.

Kamada has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Kamada

• Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability - Kamada Pharmaceuticals
• Kamada Issues 2024 CEO Letter to Shareholders - Kamada Pharmaceuticals
• Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024 Company to Host Conference Call at 8:30am ET - Kamada Pharmaceuticals
• Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years - Kamada Pharmaceuticals
• Kamada Reports Significant Increase in Sales and Profitability in the Third Quarter and Nine Month 2023; Reiterates 2023 Revenue and Profitability Guidance - Kamada Pharmaceuticals
• Kamada to Announce Third Quarter and First Nine Months Ended September 30, 2023 Financial Results and Host Conference Call on November 13, 2023 - Kamada Pharmaceuticals
• Kamada Provides Corporate Update on its Israel Operations - Kamada Pharmaceuticals
• Kamada Announces Recent Achievements with CYTOGAM® including Availability of Product Manufactured by the Company for U.S Commercial Sale and Presentation of New Clinical Data - Kamada Pharmaceuticals
• News - Kamada Pharmaceuticals
• Kamada Reports Strong Second Quarter and First Half 2023 Financial Results; Reiterates 2023 Revenue and Profitability Guidance - Kamada Pharmaceuticals
• View more press releases Close

Social media about Kamada

• Kamada on Wikipedia, Google News & Yahoo Finance
• Kamada on LinkedIn, Twitter & YouTube

Contact by email its executives including Amir London

Call Kamada at +972 ...

View the org chart

Register to receive your alert

Report an error